IMAAVY (nipocalimab)shows over two years of sustained disease control in a broad population with generalised myasthenia gravis (gMG)
Through 120 weeks of follow-up, nipocalimab delivered sustained clinical improvements and reductions…
Catheter Precision to Attend and Share New Clinical Data at the 47th Annual Heart Rhythm Society Meeting
April 23, 2026 12:00 ET | Source: Catheter Precision, Inc. VIVO System…
SkinHealth Systems Inc. Appoints Three New Independent Directors to Board
Kenneth Tripp, Dr. Sachin Shridharani, and E. Scott Beattie bring deep expertise…
TOMI Environmental Solutions Scales Automation with SteraMist iHP Robot Upgrade; Targets Fast Growing Robotaxi Market
Pairing Decontamination Versatility with Domestic Lithium Power to Meet the Global Demand…
Abivax to Present Data on Obefazimod at Digestive Disease Week
Abivax to Present Data on Obefazimod at Digestive Disease Week® Presentations Highlight…
Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting
Single-dose of miv-cel achieved robust and durable improvements in mobility, reversed disability…
RNK Health NAD+ Longevity Therapy Claims Evaluated: The Clinician-Guided NAD Injections & Medication Protocol
Des Moines, IA, April 21, 2026 (GLOBE NEWSWIRE) -- The information below…
Revolution Medicines to Present Updated Phase 1/2 Clinical Data for Daraxonrasib in First Line Metastatic Pancreatic Cancer Across Monotherapy and Combination Cohorts at the 2026 AACR Annual Meeting
REDWOOD CITY, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc.…
Enjoin Launches Technology-First Rebrand For Scalable Revenue Integrity
Photo Courtesy of Enjoin NASHVILLE, Tenn., April 20, 2026 (GLOBE NEWSWIRE) --…
